Get Support

Learn Mode

DVA - DaVita Inc

43

$147.91

-$0.22 (-0.149%)

At market close

$147.62

-$0.29 (-0.196%)

After Hours 4/17/26, 9:48 PM

3.29/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

DVA

Valuation Score

View as %

Stock Unlock

1D

1W

1M

YTD

1Y

3Y

5Y

Max

Stock Profile

Market Cap

$9.88B

Industry

Health Care

EPS (TTM)

$10.48

P/E (TTM)

13.23

Div & Yield

--

FCF Payout Ratio

--

P/S (TTM)

0.72

P/B

0.00

Diluted Shares

71.21M

Ex-Dividend

--

Next Earnings

05-11

Forward P/E

10.18

Payout Ratio

--

P/FCF (TTM)

7.54

FCF Yield

13.27%

Earnings Yield

7.56%

52 Week Range

Score Card

Explore Scores Tab

3.29

Average

DaVita Inc has grown revenue at 6.46% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -15.05% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

1.00

Very Bad

Management

1.00

Very Bad

Growth

4.00

Good

Profitability

2.00

Bad

Fin. Health

1.00

Very Bad

Dividends

--

--

Analyst

4.00

Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

Filter Form Types

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 17:39:34

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:10:27

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:10:18

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:10:04

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:56

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:49

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:42

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:35

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:29

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:21

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:16

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-17 16:09:09

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-12

High:

$199.50

34.9%

Avg:

$154.54

4.5%

Low:

$127.26

-14.0%

(% change is relative to the current stock price: $147.91)

Analyst Recommendations

Go to Analyst Tab

3.43

Good

7%

Strong Buy (1)

36%

Buy (5)

50%

Hold (7)

7%

Sell (1)

0%

Strong Sell (0)

About

Website
https://www.davita.com/
Address
2000 16th St, Denver COLORADO, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=927066

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

IPO Date

1995-10-31

Industry

Health Care

Total Employees

78,000

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Health Care Providers & Services

GICS Sub

Health Care Services

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services